Steris (STE) Tops Q2 EPS by 6c
Tweet
Share
E-mailGet Alerts STE Hot Sheet
Price: $207.27 +2.00%
Revenue Growth %: +7.9%
Financial Fact:
Net (loss) income: 8.69M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Revenue Growth %: +7.9%
Financial Fact:
Net (loss) income: 8.69M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Steris (NYSE: STE) reported Q2 EPS of $0.68, $0.06 better than the analyst estimate of $0.62. Revenue for the quarter came in at $462.7 million versus the consensus estimate of $452.5 million.
Steris sees FY2015 EPS of $2.86-$2.91, versus the consensus of $2.87.
For earnings history and earnings-related data on Steris (STE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan raises S&P 500 target to 7,800, says earnings revision ’unprecedented’
- Virax Biolabs announces 1-for-25 reverse stock split on Nasdaq
- Benchmark Reiterates Buy Rating on Cineverse (CNVS) Ahead of Q4 Results
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Guidance, Trader Talk, Trading HaltsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
